title: Hematologic improvement after flavopiridol treatment of pentostatin and rituximab refractory hairy cell leukemia.
authors.forename: Jeffrey A
authors.initials: JA
authors.lastname: Jones
authors.forename: Eric H
authors.initials: EH
authors.lastname: Kraut
authors.forename: Deidre
authors.initials: D
authors.lastname: Deam
authors.forename: John C
authors.initials: JC
authors.lastname: Byrd
authors.forename: Michael R
authors.initials: MR
authors.lastname: Grever
mesh_terms: D000368:Aged; D058846:Antibodies, Monoclonal, Murine-Derived / Q000494:pharmacology* / Q000627:therapeutic use; D000970:Antineoplastic Agents / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D019008:Drug Resistance, Neoplasm; D005419:Flavonoids / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D006801:Humans; D006947:Hyperkalemia / Q000139:chemically induced; D007372:Interferons / Q000008:administration & dosage; D007943:Leukemia, Hairy Cell / Q000188:drug therapy* / Q000601:surgery; D008297:Male; D015649:Pentostatin / Q000494:pharmacology* / Q000627:therapeutic use; D010880:Piperidines / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D047428:Protein Kinase Inhibitors / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D012074:Remission Induction; D000069283:Rituximab; D013156:Splenectomy
chemical_list: D058846:Antibodies, Monoclonal, Murine-Derived; D000970:Antineoplastic Agents; D005419:Flavonoids; D010880:Piperidines; D047428:Protein Kinase Inhibitors; D015649:Pentostatin; C077990:alvocidib; D000069283:Rituximab; D007372:Interferons